Description
Lenvatinib (trade name Lenvima) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.
- API
- antitumor&
- anti-cancer
Production Capacity:
Not informed
Delivery Timeframe:
Not informed
Incoterms:
Not informedPackaging Details:
Not informed
More about
Hangzhou Royall Import & Export Co., Ltd.
Not informed
Not informed
Not informed
Year
Established
Business type
- Industry / Manufacturer
- Importer / Trading Company
Keywords
- Active Pharmaceutical Ingredients (API)
- Pharmaceutical Intermediates
- Contrast Agent Supplier
- Iohexol Manufacturer
- Custom Synthesis Services
- Peptide API
- Pharmaceutical Machinery
- GMP Validation Services
- Contract Manufacturing (Pharma)
- Distilled Water Machine Ver Mais
Contact and location
-
Mory ********
-
+86 1********
-
杭州 / | China